Top 10 High Tech Stocks To Own For 2019


"I remember when the Dow hit 1,000, and then 2,000," a friend in his 70s told me last month at lunch…   "Now the Dow's near 20,000. That's scary."   This friend is no dummy… He founded a major corporation that traded on the stock market. He had tens of thousands of employees. His net worth hit nine figures.   And he's scared. I get that… We're in uncharted territory. But I have a positive message today:   Stocks can go much higher this year. And there are two major reasons why.   Let me explain them both…   First, fearing new highs simply doesn't make sense. But I do understand why it happens.   If prices hit a new all-time high, then they only have two potential places to go… somewhere they've already been, or somewhere they've never been.

Top 10 High Tech Stocks To Own For 2019: 58.com Inc.(WUBA)


Advisors’ Opinion:

  • [By Logan Wallace]

    58.com (NYSE:WUBA) was downgraded by TheStreet from a “b-” rating to a “c+” rating in a research report issued on Thursday.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Best Buy Co., Inc. (NYSE: BBY) is projected to report quarterly earnings at $0.74 per share on revenue of $8.73 billion.
    McKesson Corporation (NYSE: MCK) is expected to report quarterly earnings at $3.56 per share on revenue of $51.25 billion.
    Medtronic plc (NYSE: MDT) is estimated to report quarterly earnings at $1.39 per share on revenue of $8.00 billion.
    Hormel Foods Corporation (NYSE: HRL) is projected to report quarterly earnings at $0.45 per share on revenue of $2.39 billion.
    Brady Corporation (NYSE: BRC) is expected to report quarterly earnings at $0.49 per share on revenue of $291.47 million.
    Sanderson Farms, Inc. (NASDAQ: SAFM) is projected to report quarterly earnings at $2.2 per share on revenue of $841.75 million.
    The Toronto-Dominion Bank (NYSE: TD) is estimated to report quarterly earnings at $1.16 per share on revenue of $6.86 billion.
    Royal Bank of Canada (NYSE: RY) is expected to report quarterly earnings at $1.61 per share on revenue of $8.05 billion.
    58.com Inc. (NYSE: WUBA) is projected to report quarterly earnings at $0.21 per share on revenue of $372.49 million.
    Luxoft Holding, Inc. (NYSE: LXFT) is estimated to report quarterly earnings at $0.59 per share on revenue of $228.53 million.
    The Toro Company (NYSE: TTC) is expected to report quarterly earnings at $1.21 per share on revenue of $916.73 million.
    StealthGas Inc. (NASDAQ: GASS) is projected to report quarterly earnings at $0.06 per share on revenue of $37.75 million.
    Stage Stores, Inc. (NYSE: SSI) is estimated to report earnings for its first quarter.
    Thermon Group Holdings, Inc. (NYSE: THR) is projected to report quarterly earnings at $0.2 per share on revenue of $96.24 million.
    Tuniu Corporation (NASDAQ: TOUR) is estimated to report quarterly loss at $0.03 per share on revenue of $76.72 million.


     

  • [By Joseph Griffin]

    21Vianet Group (NASDAQ: VNET) and 58.com (NYSE:WUBA) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations and institutional ownership.

  • [By Stephan Byrd]

    Sabre (NASDAQ: SABR) and 58.com (NYSE:WUBA) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, risk, valuation and profitability.

  • [By Shane Hupp]

    58.com Inc (NYSE:WUBA) has been assigned an average rating of “Buy” from the ten research firms that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $78.20.

  • [By Joseph Griffin]

    US Bancorp DE cut its stake in 58.com Inc (NYSE:WUBA) by 23.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,088 shares of the information services provider’s stock after selling 646 shares during the quarter. US Bancorp DE’s holdings in 58.com were worth $167,000 as of its most recent filing with the Securities & Exchange Commission.

Top 10 High Tech Stocks To Own For 2019: Portola Pharmaceuticals, Inc.(PTLA)


Advisors’ Opinion:

  • [By Todd Campbell]

    In this episode of The Motley Fool’s Industry Focus: Healthcare, analysts Kristine Harjes and Todd Campbell discuss if the criticism is fair and if athenahealth’s likely to be acquired. Also, they update investors onTakeda’s plan to merge withShire Plc(NASDAQ:SHPG) in a $62 billion deal and howpatience finally paid off forPortola Pharmaceuticals(NASDAQ:PTLA) investors.

  • [By Lisa Levin] Gainers
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 34.7 percent to $45.50 in pre-market trading following news that the FDA has approved Andexxa for the reversal of factor Xa inhibitors.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 15.7 percent to $6.65 in pre-market trading after climbing 155.56 percent on Thursday.
    China Recycling Energy Corporation (NASDAQ: CREG) rose 14.7 percent to $2.75 in pre-market trading after climbing 57.89 percent on Thursday.
    Pandora Media, Inc. (NYSE: P) rose 11 percent to $6.40 in pre-market trading after reporting strong quarterly results.
    Fred's, Inc. (NASDAQ: FRED) rose 9.2 percent to $1.90 in pre-market trading following Q4 results.
    Shake Shack Inc (NYSE: SHAK) rose 9.1 percent to $51.70 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) rose 9 percent to $12.55 in pre-market trading after the company posted Q1 results and agreed to acquire HealthGrid.
    Weight Watchers International, Inc. (NYSE: WTW) rose 7.6 percent to $75 in pre-market trading after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings outlook from $2.40-$2.70 to $3-$3.20.
    Viavi Solutions Inc. (NASDAQ: VIAV) rose 7.5 percent to $10.15 in pre-market trading following Q3 results.
    Pearson plc (NYSE: PSO) rose 4.5 percent to $11.83 in pre-market trading after reporting strong quarterly earnings.
    Alibaba Group Holding Ltd (NYSE: BABA) shares rose 4.4 percent to $190.50 in the pre-market trading session as the company posted upbeat Q4 results.
    Aqua Metals, Inc. (NASDAQ: AQMS) shares rose 3.9 percent to $4.30 in pre-market trading after gaining 6.98 percent on Thursday.
    Newell Brands Inc (NYSE: NWL) shares rose 3.6 percent to $27.65 in pre-market trading after reporting upbeat quarterly earnings.
    HMS Holdings Corp (NASDAQ: H
  • [By Lisa Levin]

    Shares of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) got a boost, shooting up 25 percent to $42.23 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.

  • [By Lisa Levin] Gainers
    Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares rose 35.8 percent to $3.00.
    Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares surged 32 percent to $8.94 after reporting upbeat Q1 earnings.
    Carbon Black, Inc. (NASDAQ: CBLK) gained 29.6 percent to $24.62. Carbon Black priced its IPO at $19 per share.
    California Resources Corporation (NYSE: CRC) shares rose 26.8 percent to $32.70 following upbeat Q1 earnings.
    Pandora Media, Inc. (NYSE: P) gained 25 percent to $7.185 after reporting strong quarterly results.
    Medifast, Inc. (NYSE: MED) shares climbed 23.7 percent to $122.87 after the company reported strong Q1 results and raised its FY18 guidance.
    Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.2 percent to $8.4999 after reporting Q2 results.
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) gained 22.2 percent to $41.27 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.
    Shake Shack Inc (NYSE: SHAK) rose 22.2 percent to $57.955 after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Atomera Incorporated (NASDAQ: ATOM) jumped 19.7 percent to $6.12 after reporting Q1 results.
    Super Micro Computer, Inc. (NASDAQ: SMCI) rose 16.4 percent to $21.00 after reporting strong preliminary results for the third quarter.
    Titan International, Inc. (NYSE: TWI) shares rose 16.4 percent to $12.21 following Q1 earnings.
    Integer Holdings Corporation (NYSE: ITGR) shares gained 14.9 percent to $63.75 following Q1 results.
    Control4 Corporation (NASDAQ: CTRL) shares climbed 14.5 percent to $23.98 folloiwng strong Q1 results.
    B&G Foods, Inc. (NYSE: BGS) climbed 12.6 percent to $25.40 after reporting Q1 earnings.
    HMS Holdings Corp (NASDAQ: HMSY) shares gained 10 percent to $19.59 after reporting upbeat quarterly earnings.
    Viavi Solutions Inc. (NASDAQ: VIAV) rose 7 percent to $10.09 following Q3 r
  • [By Logan Wallace]

    Portola Pharmaceuticals (NASDAQ:PTLA) has been given a $80.00 target price by equities research analysts at Oppenheimer in a research note issued to investors on Sunday. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. Oppenheimer’s price target points to a potential upside of 88.50% from the stock’s previous close.

  • [By Lisa Levin]

    Shares of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) got a boost, shooting up 21 percent to $40.90 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.

Top 10 High Tech Stocks To Own For 2019: Bravo Brio Restaurant Group Inc.(BBRG)


Advisors’ Opinion:

  • [By Stephan Byrd]

    Media coverage about Bravo Brio Restaurant Group (NASDAQ:BBRG) has trended positive on Saturday, Accern Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Bravo Brio Restaurant Group earned a daily sentiment score of 0.39 on Accern’s scale. Accern also assigned media coverage about the restaurant operator an impact score of 45.847415840944 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Logan Wallace]

    Media coverage about Bravo Brio Restaurant Group (NASDAQ:BBRG) has been trending positive on Friday, Accern Sentiment reports. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Bravo Brio Restaurant Group earned a media sentiment score of 0.46 on Accern’s scale. Accern also gave media stories about the restaurant operator an impact score of 48.5554072096128 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 10 High Tech Stocks To Own For 2019: Galmed Pharmaceuticals Ltd.(GLMD)


Advisors’ Opinion:

  • [By Keith Speights]

    That’s exactly what happened this week with three small biotech stocks. Galmed Pharmaceuticals (NASDAQ:GLMD), Galectin Therapeutics (NASDAQ:GALT), and Eloxx Pharmaceuticals (NASDAQ:ELOX) soared on news that excited investors. Here’s what drove these stocks higher — and whether or not they’re smart picks for investors now.

  • [By Shane Hupp]

    Here are some of the media stories that may have effected Accern’s rankings:


    Get Galmed Pharmaceuticals alerts:

    Galmed Pharmaceuticals’ (GLMD) CEO Allen Baharaff on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) What You Must Know About Galmed Pharmaceuticals Ltds (NASDAQ:GLMD) Market Risks (finance.yahoo.com) Obeticholic Acid Market Analysis, Recent Trends and Regional Growth Forecast by Types, Applications and Economic … (theexpertconsulting.com) oholic Steatohepatitis (NASH) Market 2023: Know Marketing Channel Future Trend, Growth and Price with Future … (theexpertconsulting.com) Umbilical Cord Blood May Offer Early FH Diagnosis (medscape.com)


    A number of equities analysts have recently commented on GLMD shares. ValuEngine lowered shares of Galmed Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Wednesday, February 14th. Maxim Group set a $14.00 price target on shares of Galmed Pharmaceuticals and gave the stock a “buy” rating in a report on Wednesday, May 9th. Finally, HC Wainwright lifted their price target on shares of Galmed Pharmaceuticals from $18.00 to $24.00 and gave the stock a “buy” rating in a report on Monday, February 12th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $20.40.

  • [By George Budwell]

    Shares of the clinical-stage biotech Galmed Pharmaceuticals (NASDAQ:GLMD) are on absolute fire this morning, thanks to a positive midstage trial readout for its experimental nonalcoholic steatohepatitis (NASH) drug Aramchol. Specifically, the company reported that patients receiving the 400 mg dose of Aramchol exhibited a significant reduction in liver fat over the study period compared to those taking a placebo. Curiously, though, patients receiving the higher dose of 600 mg apparently only showed a statistically significant drop in liver fat relative to placebo patients in a post-hoc analysis, according to the press release.

  • [By Sean Williams]

    Similar strength was seen from microcap Galmed Pharmaceuticals (NASDAQ:GLMD), which rose by more than 150% during a single trading session two weeks ago despite mixed results. The move followed the release of phase 2b data from its 52-week Arrest study for NASH drug hopeful Aramchol. In that trial, a statistically significant reduction in liver fat was noted with one of the two doses (the 400 mg dose). However, the 600 mg dose led to a statistically significant improvement in overall NASH resolution (19.2% vs. 7.5%) and NASH resolution without worsening of fibrosis (16.7% vs. 5%) relative to the placebo.

Top 10 High Tech Stocks To Own For 2019: Impax Laboratories, Inc.(IPXL)


Advisors’ Opinion:

  • [By Max Byerly]

    News articles about Impax Laboratories (NASDAQ:IPXL) have trended somewhat positive on Sunday, according to Accern Sentiment. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Impax Laboratories earned a daily sentiment score of 0.08 on Accern’s scale. Accern also gave news coverage about the specialty pharmaceutical company an impact score of 43.4189030940397 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Top 10 High Tech Stocks To Own For 2019: SORL Auto Parts Inc.(SORL)


Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Lisa Levin]

    Shares of SORL Auto Parts, Inc. (NASDAQ: SORL) got a boost, shooting up 13 percent to $5.90 after reporting upbeat Q1 results.

    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares were also up, gaining 24 percent to $27.3947 following Q3 results.

  • [By Max Byerly]

    SORL Auto Parts (NASDAQ: SORL) and Modine Manufacturing (NYSE:MOD) are both small-cap auto/tires/trucks companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations and risk.

Top 10 High Tech Stocks To Own For 2019: FormFactor, Inc.(FORM)


Advisors’ Opinion:

  • [By Max Byerly]

    FormFactor, Inc. (NASDAQ:FORM) – Equities researchers at B. Riley dropped their FY2018 earnings per share (EPS) estimates for FormFactor in a research report issued to clients and investors on Monday, July 30th. B. Riley analyst C. Ellis now anticipates that the semiconductor company will post earnings of $0.74 per share for the year, down from their prior forecast of $0.98. B. Riley currently has a “Buy” rating and a $18.00 target price on the stock. B. Riley also issued estimates for FormFactor’s Q3 2019 earnings at $0.27 EPS, Q4 2019 earnings at $0.31 EPS and FY2019 earnings at $1.07 EPS.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on FormFactor (FORM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Feroldi]

    FormFactor(NASDAQ:FORM), which manufactures testing equipment for semiconductor components, reported its second-quarter results on Wednesday, andas expected, the company posted year-over-year declines in revenue and profits. However, the declines were not as bad as management had projected. Margins alsoheld up well during the trying period. Traders bid up the stock in response to the better-than-expected quarterly results and on the hope that the bottom is in the rearview mirror.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

Top 10 High Tech Stocks To Own For 2019: America Movil, S.A.B. de C.V.(AMOV)


Advisors’ Opinion:

  • [By Ethan Ryder]

    News stories about America Movil SAB de CV ADR Class A (NYSE:AMOV) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. America Movil SAB de CV ADR Class A earned a coverage optimism score of 0.23 on Accern’s scale. Accern also gave news headlines about the company an impact score of 47.3307585784002 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Stephan Byrd]

    Am茅rica M贸vil (NYSE:AMOV)’s share price reached a new 52-week high and low on Wednesday . The stock traded as low as $15.49 and last traded at $15.49, with a volume of 100 shares trading hands. The stock had previously closed at $15.49.

Top 10 High Tech Stocks To Own For 2019: Gol Linhas Aereas Inteligentes S.A.(GOL)

Advisors’ Opinion:

  • [By Max Byerly]

    Gol Transportes A茅reos (NYSE:GOL) shares traded down 5.4% on Monday . The company traded as low as $9.72 and last traded at $9.75. 524,965 shares traded hands during mid-day trading, an increase of 40% from the average session volume of 374,811 shares. The stock had previously closed at $10.31.

Top 10 High Tech Stocks To Own For 2019: Transcat, Inc.(TRNS)

Advisors’ Opinion:

  • [By Shane Hupp]

    Headlines about Transcat (NASDAQ:TRNS) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Transcat earned a news impact score of 0.18 on Accern’s scale. Accern also assigned news headlines about the scientific and technical instruments company an impact score of 45.1994165476044 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.